Luciferin Amides for Bioluminescent FAAH Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for fatty acid amide hydrolase (FAAH) activity are limited in terms of speed, sensitivity, and compatibility, particularly for rapid assays or imaging in live cells or organisms, and require methods like HPLC or radioactivity for detection.
Innovation Solution
The use of luciferin amides as selective bioluminescent sensors to detect FAAH activity in vitro, in live cells, and in vivo, which are more sensitive than conventional coumarin-based sensors and allow detection at lower dosages, enabling imaging methods involving luciferase-expressing cells and animals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional HPLC or radioactivity methods are used for FAAH activity detection, then detection accuracy is maintained, but assay speed is slow and sensitivity is limited
Solution Approach 1:
The patent replaces conventional HPLC mechanical separation and radioactivity detection systems with a bioluminescence-based optical detection system. Luciferin amides serve as substrates that produce light signals when metabolized by FAAH, enabling rapid, sensitive detection without complex mechanical systems while maintaining measurement accuracy.
Solution Approach 2:
The patent changes the detection parameter from chemical analysis (HPLC) or radioactivity measurement to optical signal detection (bioluminescence). This parameter change enables real-time monitoring of FAAH activity with high sensitivity and rapid response, resolving the contradiction between detection accuracy and assay speed.
2Measurement precision
If conventional coumarin-based sensors are used for FAAH detection, then detection capability is achieved, but sensitivity is insufficient
Solution Approach 1:
The patent changes the sensor molecule from coumarin-based fluorescent sensors to luciferin-based bioluminescent sensors. This parameter change in the detection system provides significantly enhanced sensitivity, allowing detection of FAAH activity at lower substrate concentrations and improving the signal-to-noise ratio.
3Illumination intensity
If standard luciferin dosages are used for bioluminescent imaging, then signal detection is achieved, but dosage requirements are too high for sensitive detection
Solution Approach 1:
The patent introduces luciferin amides as intermediary substrates that are metabolized by FAAH to generate the active luciferin signal. This intermediary approach amplifies the detection signal while reducing the required dosage, as the enzymatic conversion process concentrates the signal generation at the target site.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Luciferin amides provide a highly sensitive and effective means for detecting FAAH activity, enabling bioluminescent imaging in live cells and organisms with improved sensitivity and lower dosage requirements compared to conventional methods, facilitating the detection of FAAH activity in various biological contexts.
Implementation Method 1
certain luciferin amides (e.g., amides derived from firefly luciferin and their analogs) can be used as selective bioluminescent sensors to detect FAAH activity
Implementation Method 2
fatty acid amide hydrolase (FAAH) is of great interest as a target for pharmaceuticals because fatty acid amides are important cellular messengers
Data Source
AI summary
This disclosure relates to luciferin amides of formula (I) shown below:Each variable in formula (I) is defined in the specification. These compounds can be used to detect fatty acid amide hydrolase activities in vitro, in live cells, or in vivo.